Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2025-09-26 00:00:00 ET · period of report 2025-09-25 · accession 0001193125-25-220847 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-09-26 | 2025-09-25 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $9.77 | -25.8K | 804.3K | -3% | -$252.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-09-25 | S | D | 25,797 | $9.77 | 804,268 | D | — | — |